87 related articles for article (PubMed ID: 8099745)
1. Towards a synthetic malaria vaccine: cyclization of a peptide eliminates the production of parasite-unreactive antibody.
Etlinger HM; Trzeciak A
Philos Trans R Soc Lond B Biol Sci; 1993 Apr; 340(1291):69-72. PubMed ID: 8099745
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses to a synthetic peptide-based malaria vaccine candidate: influence of sequence variants of the peptide.
Etlinger HM; Renia L; Matile H; Manneberg M; Mazier D; Trzeciak A; Gillessen D
Eur J Immunol; 1991 Jun; 21(6):1505-11. PubMed ID: 2044658
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
[TBL] [Abstract][Full Text] [Related]
5. New B cell epitopes in the Plasmodium falciparum malaria circumsporozoite protein.
Stüber D; Bannwarth W; Pink JR; Meloen RH; Matile H
Eur J Immunol; 1990 Apr; 20(4):819-24. PubMed ID: 1693336
[TBL] [Abstract][Full Text] [Related]
6. Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.
Etlinger HM; Heimer EP; Trzeciak A; Felix AM; Gillessen D
Immunology; 1988 Jul; 64(3):551-8. PubMed ID: 3044983
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
Bongfen SE; Ntsama PM; Offner S; Smith T; Felger I; Tanner M; Alonso P; Nebie I; Romero JF; Silvie O; Torgler R; Corradin G
Vaccine; 2009 Jan; 27(2):328-35. PubMed ID: 18984024
[TBL] [Abstract][Full Text] [Related]
8. Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization.
Gerloni M; Baliou WR; Billetta R; Zanetti M
Nat Biotechnol; 1997 Sep; 15(9):876-81. PubMed ID: 9306403
[TBL] [Abstract][Full Text] [Related]
9. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.
Etlinger HM; Felix AM; Gillessen D; Heimer EP; Just M; Pink JR; Sinigaglia F; Stürchler D; Takacs B; Trzeciak A
J Immunol; 1988 Jan; 140(2):626-33. PubMed ID: 3275719
[TBL] [Abstract][Full Text] [Related]
10. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.
Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH
J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341
[TBL] [Abstract][Full Text] [Related]
11. Induction of antibodies against the Plasmodium falciparum p126 antigen in non-responder H-2b and partial-responder H-2d mice using synthetic peptides.
Gilardeau Truffinet M; Bossus M; Camus D; Delplace P; Mazingue C; Diesis E; Tartar A; Moreau S; Gras-Masse H; Banic DM
Pept Res; 1996; 9(2):61-70. PubMed ID: 8738980
[TBL] [Abstract][Full Text] [Related]
12. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25.
Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B
Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417
[TBL] [Abstract][Full Text] [Related]
13. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cellular and humoral responses to recombinant protein and synthetic peptides of exon2 region of Plasmodium falciparum erythrocyte membrane protein1 (PfEMP1) among malaria patients from an endemic region.
Das P; Grewal JS; Mahajan B; Chauhan VS
Parasitol Int; 2007 Mar; 56(1):51-9. PubMed ID: 17258500
[TBL] [Abstract][Full Text] [Related]
15. Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design.
Singh S; Soe S; Mejia JP; Roussilhon C; Theisen M; Corradin G; Druilhe P
J Infect Dis; 2004 Sep; 190(5):1010-8. PubMed ID: 15295710
[TBL] [Abstract][Full Text] [Related]
16. IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes.
Chappel JA; Hollingdale MR; Kang AS
Hum Antibodies; 2004; 13(3):91-6. PubMed ID: 15598989
[TBL] [Abstract][Full Text] [Related]
17. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.
Pratt-Riccio LR; Lima-Junior JC; Carvalho LJ; Theisen M; Espíndola-Mendes EC; Santos F; Oliveira-Ferreira J; Goldberg AC; Daniel-Ribeiro CT; Banic DM
Am J Trop Med Hyg; 2005 Dec; 73(6):1096-103. PubMed ID: 16354819
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein.
Moorthy SA; Yasawardena SG; Ramasamy R
Vaccine; 2009 Aug; 27(36):4947-52. PubMed ID: 19545652
[TBL] [Abstract][Full Text] [Related]
19. [Use of synthetic carriers and adjuvants for increasing the immunogenicity of a synthetic peptide from the CS-protein of Plasmodium falciparum].
Ivanov BB; Meshcheriakova EA; Andronova TM; Ivanov VT
Bioorg Khim; 1991 Jun; 17(6):732-46. PubMed ID: 1723268
[TBL] [Abstract][Full Text] [Related]
20. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
